Interestingly, in a mouse colitis model it was shown that the deletion of IKK in intestinal epithelial cells down-regulated expression of pro-inflammatory cytokines, highlighting the crucial role of inflammation in supporting cancer and indicating that specific blocking of the pro-inflammatory IKK/NF-κB pathway may be an attractive and promising therapeutic target [74]. Here, NFKB1 is linked to cancer.